TERE1 Activators

TERE1 Activators, as listed, are primarily compounds that can potentially influence the activity or expression of TERE1/UBIAD1 indirectly. These compounds are not direct activators but could play a role in modulating the metabolic pathways in which UBIAD1 is involved, particularly in cholesterol and coenzyme Q10 synthesis. Compounds like Statins (e.g., Simvastatin, Atorvastatin, Rosuvastatin) are known to inhibit HMG-CoA reductase, a key enzyme in cholesterol biosynthesis. This inhibition can potentially impact UBIAD1, which is also involved in cholesterol metabolism. The relationship between cholesterol metabolism and UBIAD1 function is complex and still under investigation, but these compounds might offer insights into how cholesterol synthesis modulation can impact UBIAD1 activity.

Vitamin K2 and Coenzyme Q10, as products or components of the pathways involving UBIAD1, are also crucial. Supplementation with these compounds might affect the regulatory mechanisms of UBIAD1, providing feedback that influences its activity. Additionally, precursors in the biosynthesis of these compounds, such as Geranylgeraniol and Farnesol, could also play a role in modulating UBIAD1 activity. Other compounds like NMN, PQQ, Resveratrol, Quercetin, and EGCG are known for their broad impact on cellular metabolism and health. While they are not directly linked to UBIAD1 function, their roles in promoting cellular health and metabolic balance could indirectly influence UBIAD1 activity, especially considering its involvement in essential biosynthetic processes.